Cape Town-based Biotech Africa is launching a new testing platform that will allow for the ultra-high throughput of Covid-19 tests, at a fraction of the current testing costs. This is in response to the shortage of test kits in South Africa, which has resulted in only around three and a half million tests having been conducted in a population of close to 60 million.
Read full article here: Bizcommunity



leave a comment here